CRIZAC vs ENTERO: Stock Comparison
Entero Healthcare Solutions Limited is the larger company by market capitalisation. Crizac Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Entero Healthcare Solutions Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CRIZAC leads 9; ENTERO leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | CRIZAC | ENTERO |
|---|---|---|
| Sector | Consumer Services | Consumer Services |
| Industry | Internet & Catalogue Retail | Pharmacy Retail |
Price
| Metric | CRIZAC | ENTERO |
|---|---|---|
| Live Price | ₹176.9 | ₹1,407.4 |
| Day Change | -1.35% | -0.65% |
| Volume | 97,079 | 38,526 |
| 52-Week High | ₹387.95 | ₹1,467.8 |
| 52-Week Low | ₹173.35 | ₹944 |
| Distance from 52W High | -54.4% | -4.12% |
Valuation
| Metric | CRIZAC | ENTERO |
|---|---|---|
| Market Cap | ₹3,102 Cr | ₹6,139 Cr |
| P/E Ratio | 14.29x | 49.29x |
| P/B Ratio | 5.39x | 3.66x |
| EPS | ₹12.59 | ₹28.76 |
| Book Value | ₹33.41 | ₹388.09 |
| Dividend Yield | 8.92% | 0% |
Growth
| Metric | CRIZAC | ENTERO |
|---|---|---|
| Revenue Growth (TTM YoY) | 15% | 42.6% |
| EPS Growth (TTM YoY) | 50.5% | 9.1% |
| Qtr Sales Growth | 15% | 42.6% |
| Qtr Profit Growth | 50.3% | 9.03% |
Profitability & Leverage
| Metric | CRIZAC | ENTERO |
|---|---|---|
| ROE | 40.3% | 6.99% |
| ROCE | 52.3% | 10.6% |
| Net Margin | 21.03% | 1.75% |
| Operating Margin | 27.4% | 4.04% |
| Debt to Equity | 0x | 0.4x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | CRIZAC | ENTERO |
|---|---|---|
| Promoter Holding | 79.94% | 14.4%▼ 0.01 pp |
| FII Holding | 1.61%▼ 0.68 pp | 4.37%▲ 0.34 pp |
| DII Holding | 3.22%▼ 0.26 pp | 15.48%▼ 1.14 pp |
| Public Holding | 15.23%▲ 0.94 pp | 27.75%▲ 0.82 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Crizac Limited and Entero Healthcare Solutions Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.